Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVO

Novo Nordisk ADR

Mar 17 • 02:13PM ET

80.13

Dollar change +2.98
Percentage change 3.86	%

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY PFE MRK ABBV BMY JNJ AMGN REGN GILD VRTX

| Held by: AVDE PPH NUGO DFIC APIE PID RVER OZEM DFAI DFAX

Scroll to Statements

Index	-	P/E	24.41	EPS (ttm)	3.28	Insider Own	0.01%	Shs Outstand	3.37B	Perf Week	1.49%
Market Cap	269.57B	Forward P/E	16.63	EPS next Y	4.82	Insider Trans	0.00%	Shs Float	3.36B	Perf Month	1.65%
Income	14.65B	PEG	1.22	EPS next Q	0.89	Inst Own	10.12%	Short Float	0.40%	Perf Quarter	-28.26%
Sales	42.09B	P/S	6.40	EPS this Y	22.92%	Inst Trans	0.02%	Short Ratio	1.47	Perf Half Y	-41.37%
Book/sh	4.49	P/B	17.86	EPS next Y	24.01%	ROA	26.33%	Short Interest	13.51M	Perf Year	-39.97%
Cash/sh	1.09	P/C	73.79	EPS next 5Y	20.02%	ROE	82.03%	52W Range	73.80 - 148.15	Perf YTD	-6.85%
Dividend Est.	1.93 (2.41%)	P/FCF	25.19	EPS past 5Y	21.74%	ROI	45.25%	52W High	-45.91%	Beta	0.57
Dividend TTM	1.45 (1.80%)	Quick Ratio	0.55	Sales past 5Y	18.58%	Gross Margin	84.67%	52W Low	8.58%	ATR (14)	3.13
Dividend Ex-Date	Mar 31, 2025	Current Ratio	0.74	EPS Y/Y TTM	21.42%	Oper. Margin	44.94%	RSI (14)	43.65	Volatility	2.75% 2.41%
Employees	76302	Debt/Eq	0.72	Sales Y/Y TTM	24.91%	Profit Margin	34.81%	Recom	1.74	Target Price	118.35
Option/Short	Yes / Yes	LT Debt/Eq	0.62	EPS Q/Q	28.11%	Payout	34.97%	Rel Volume	0.56	Prev Close	77.15
Sales Surprise	7.50%	EPS Surprise	6.56%	Sales Q/Q	29.02%	Earnings	Feb 05 BMO	Avg Volume	9.19M	Price	80.13
SMA20	-5.53%	SMA50	-4.84%	SMA200	-29.61%	Trades		Volume	3,797,765	Change	3.86%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120
Oct-02-23	Initiated	Argus	Buy	$110
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-15-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-28-22	Downgrade	UBS	Neutral → Sell
Jun-27-22	Upgrade	Exane BNP Paribas	Underperform → Neutral
Jun-07-22	Upgrade	JP Morgan	Neutral → Overweight
May-31-22	Upgrade	Guggenheim	Neutral → Buy
Apr-25-22	Upgrade	Cowen	Market Perform → Outperform	$130
Apr-12-22	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Mar-16-22	Upgrade	Deutsche Bank	Hold → Buy
Jan-25-22	Downgrade	Liberum	Hold → Sell

Show Previous Ratings

Today 01:21PM	The cost of GLP-1s needs to come way down for benefits to be worth it, study says (Quartz)
11:26AM	Novo Nordisk Stock Rises Ahead of Data on Ozempic Ingredient's Ability to Lower Heart Risk (Investopedia)
09:30AM	Why Novo Nordisk (NVO) is a Top Stock for the Long-Term (Zacks)
09:00AM	Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock (Zacks)
06:47AM	3 Unstoppable Stocks You Can Buy Now Without Any Hesitation (Motley Fool)
05:00AM	Loading…
05:00AM	The weight loss drug shortage is over and some patients are 'panicking' (Quartz)
Mar-14-25 06:08PM	Drugmakers agree to participate in second round of price negotiations (Reuters)
10:08AM	Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell? (Investor's Business Daily)
05:00AM	An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup (Quartz)
Mar-13-25 05:45PM	Novo Nordisk (NVO) Gains As Market Dips: What You Should Know (Zacks)
12:35PM	Wall Street's Biggest Novo Nordisk Bear Just Flipped--Here's Why He Says It's Time to Buy (GuruFocus.com)
10:32AM	UiPath plunges on weak outlook, Novo Nordisk upgrade: Top Stocks (Yahoo Finance Video)
09:28AM	Novo Nordisk Skeptic Finally Upgrades Stock After Drop From Peak (Bloomberg)
Mar-12-25 07:26PM	Novo Nordisk sell-off is completely overdone, says Mizuho's Jared Holz (CNBC TV)
04:09PM	Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion (Investor's Business Daily)
04:03PM	Loading…
04:03PM	Roche, Zealand sign deal: What it means for weight loss drug space (Yahoo Finance Video)
02:23PM	Novo Nordisk Is Falling. Competition Is a Killer. (Barrons.com)
12:48PM	Novo Nordisk, Starbucks shares slumping: Trending Tickers (Yahoo Finance Video)
12:12PM	Novo Nordisk Is Falling. A Rival Weight-Loss Drug Is on the Way. (Barrons.com)
12:10PM	iRobot, Target, Novo Nordisk vs. Roche: Market Minute (Yahoo Finance Video)
12:08PM	Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped (Motley Fool)
12:02PM	Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo stock slides 4% (Yahoo Finance)
12:02PM	Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4% (Yahoo Finance)
11:56AM	Novo Nordisk Stock Slides After Roche Strikes Weight-Loss Deal (The Wall Street Journal)
10:09AM	Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly (Investopedia)
09:47AM	Novo Nordisk Stock Falls After Roche Strikes Weight-Loss Deal (The Wall Street Journal)
08:53AM	Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way. (Barrons.com)
07:26AM	NovoNordisk stock falls on Roche-Zealand pact; Jefferies cuts target (Investing.com)
Mar-11-25 04:58PM	Viking strikes $150m deal to secure supply of obesity drug (Pharmaceutical Technology)
10:05AM	Morgan Stanley says REDEFINE-2 misses opportunity to differentiate in diabetes (TipRanks)
09:51AM	Loading…
09:51AM	H.C. Wainwright says Novo results support Viking obesity potential (TipRanks)
09:16AM	Novo Nordisk Shares Drop After CagriSema Trial Data Falls Short of Expectations (GuruFocus.com)
08:35AM	Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial (Benzinga)
04:10AM	Is Eli Lilly Stock a Buy? (Motley Fool)
Mar-10-25 09:00PM	Ozempics New Frontier: The War on Aging (The Wall Street Journal) -9.43%
06:54PM	Why Eli Lilly Stock Flopped Today (Motley Fool)
04:31PM	Novo Nordisk Dives 9%. Why Eli Lilly Now Has The Upper Hand. (Investor's Business Daily)
02:31PM	Eli Lilly's first weight loss pill could expand access to GLP-1s around the globe, executive says (Quartz)
01:52PM	Novo Nordisk Shares Tumble 8% on CagriSema Weight Loss Miss (GuruFocus.com)
12:55PM	The State of Weight Loss Drugs (Motley Fool)
12:14PM	Novo Nordisks stock drops despite CagriSema hitting goal of Phase III trial (Clinical Trials Arena)
11:44AM	Novo Nordisk Stock Slides After Obesity Drug Trial Disappoints (The Wall Street Journal)
11:42AM	Stocks to Watch Monday: Apple, Tesla, Robinhood, Google (The Wall Street Journal)
11:32AM	Why Novo Nordisk Stock Is Falling Today (Motley Fool)
11:30AM	Redfin skyrockets, Novo Nordisk drops, Tesla: Market Minute (Yahoo Finance Video)
10:55AM	Novo Nordisk shares fall on weight-loss drug trial (Fox Business)
10:31AM	Novo Nordisk's Ozempic successor disappointed Wall Street again (Quartz)
10:31AM	Novo Nordisk Stock Drops on New Obesity Drug Findings. Eli Lilly Stands to Gain. (Barrons.com)
10:21AM	Novo Nordisk stock slides Monday on second-generation GLP-1 data (Yahoo Finance)
10:10AM	Novo Nordisk stock sinks on weight loss drug trial letdown (Yahoo Finance Video)
09:55AM	Novo Nordisk Shares Sink on Latest CagriSema Weight Loss Drug Study (Investopedia)
09:39AM	Stocks to Watch Monday: Novo Nordisk, Eli Lilly, QXO, Tesla (The Wall Street Journal)
09:28AM	Novos New Obesity Drug Disappoints Again, This Time in Diabetes (Bloomberg)
08:38AM	Novo Nordisk plunges following latest CagriSema data (Investing.com)
08:00AM	5 Things to Know Before the Stock Market Opens (Investopedia)
06:24AM	Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial (GlobeNewswire)
Mar-07-25 05:45PM	Novo Nordisk (NVO) Stock Dips While Market Gains: Key Facts (Zacks)
01:42PM	Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher (Fortune)
06:15AM	This Could Be a Huge Blow to Hims & Hers Health Stock (Motley Fool)
05:00AM	Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup (Quartz)
Mar-06-25 02:03PM	Hims & Hers' Weight-Loss Bet Hits a Wall--Is the Stock's $6 Billion Surge About to Unravel? (GuruFocus.com)
11:56AM	Novo Nordisk Faces a Perfect Storm: Tariff Shock and Legal Battle Threaten Its Blockbuster Drugs (GuruFocus.com)
11:33AM	Even weight loss drugs aren't safe from tariffs (Quartz)
11:12AM	'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen (Yahoo Finance)
09:07AM	Hims & Hers Stock Is Due for a Crash Diet. The Weight-Loss Drug Surge Is Fading Fast. (Barrons.com)
08:02AM	Novo Nordisk cuts Wegovy price through new direct-to-patient online pharmacy (Pharmaceutical Technology)
06:38AM	Tariff Uncertainty Is Crippling Stock Markets, but Trumps Auto Move Offers Hope. And 5 Other Things to Know Today. (Barrons.com)
05:06AM	Amgen readies pivotal MariTide trials; Novo offers discounted Wegovy (BioPharma Dive)
Mar-05-25 05:19PM	Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It (Motley Fool)
04:17PM	Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy (Investor's Business Daily)
04:00PM	The Dow surges 500 points as Trump hands out some tariff relief (Quartz)
04:00PM	GM, Novo Nordisk, Moderna, Marvell, CrowdStrike: Stocks to watch today (Quartz)
02:44PM	Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket (Investopedia)
12:59PM	Novo Nordisk Shares Climb as Wegovy Price Slashed Over 50% (GuruFocus.com)
11:59AM	Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly (Associated Press Finance)
11:51AM	Hims & Hers Hammered After Novo Nordisk Undercuts It With A Cheaper Wegovy (Investor's Business Daily)
11:37AM	Novo Nordisk's Wegovy, Apple Air, Palantir: Top Stories (Yahoo Finance Video)
11:18AM	Stocks to Watch Wednesday: Toyota, CrowdStrike, Alibaba, Novo Nordisk (The Wall Street Journal)
11:02AM	Novo Nordisk launches $499 Wegovy cash option and home delivery (Yahoo Finance)
10:56AM	Novo Nordisks Cheaper Wegovy Offering Is Bad News for Hims & Hers Stock (Barrons.com)
10:55AM	Novo Nordisk offering weight-loss drug Wegovy at huge discount (Yahoo Finance Video)
10:37AM	Why Novo Nordisk (NVO) Is Rising Today (Insider Monkey)
10:07AM	The price of Wegovy was just cut by more than half if you pay cash (Quartz)
09:51AM	Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health (Investor's Business Daily)
08:50AM	Novo Nordisk offers Wegovy at lowered cost, Hims & Hers Health shares fall (Investing.com)
08:00AM	Novo Nordisk introduces NovoCare Pharmacy, lowering cost of all doses of FDA-approved Wegovy (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients (PR Newswire)
04:37AM	Down 39%. Is Novo Nordisk Stock a Buy on the Dip? (Motley Fool)
Mar-04-25 01:04PM	GLP1 Tracker: Lilly continues to outgrow Novo- analyst (Investing.com)
Mar-03-25 04:20PM	AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion. (Investor's Business Daily)
12:25PM	Novo Nordisk and AI-driven Gensaic enter into $354m cardiometabolic deal (Pharmaceutical Technology)
09:37AM	Jim Cramer on Novo Nordisk A/S (NVO): Where Are They Going To Be In The Tariffs (Insider Monkey)
09:30AM	Wall Street Analysts See Novo Nordisk (NVO) as a Buy: Should You Invest? (Zacks)
09:00AM	Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now? (Zacks)
02:49AM	How pharma CEO pay shifted for these 4 companies last year (Pharma Voice)
Mar-02-25 01:16PM	Novo Nordisk A/S (NYSE:NVO): A Strong Pipeline to Aid Recovery (Insider Monkey)
Feb-28-25 11:49AM	Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up (Investor's Business Daily)
09:30AM	Novo Nordisk (NVO) Hit with Investor Lawsuit Over CagriSema Obesity Drug - Hagens Berman (PR Newswire)
09:00AM	Is Eli Lilly Stock A Buy As It Plays Ball With Trump To The Tune Of $27 Billion? (Investor's Business Daily)
Feb-27-25 09:46AM	Novavax reports large quarterly revenue declines, rethinks its strategic direction (Yahoo Finance)
09:03AM	Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordisk A/S (GlobeNewswire)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience